Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Nestlé S.A.    NESN   CH0038863350


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Reckitt lifts full-year revenue target as Mead Johnson deal pays off

share with twitter share with LinkedIn share with facebook
share via e-mail
07/27/2018 | 05:01am EST
FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic are seen in London

(Reuters) - British consumer goods maker Reckitt Benckiser bumped up revenue targets for the year, as the Dettol-maker benefited from its 13 billion pound deal to buy Mead Johnson, sending its shares up more than 8 percent.

The maker of Durex condoms and Lysol disinfectant raised its annual net revenue growth expectations to between 14 to 15 percent, higher than its previous target of 13 to 14 percent.

Full year like-for-like sales growth is also expected to come in at the higher end of its 2 to 3 percent range, Reckitt said, as it also signalled a recovery at its Scholl footcare brand, which has struggled for the last two years.

The company said its infant and child nutrition division, the acquired Mead Johnson business, was experiencing strong growth above medium-term expectations, led by China, the world's largest market for the products.

Reckitt bought the U.S. firm, which makes baby formulas Enfamil and Nutramigen, in 2017, to expand into developing markets and new product ranges.

The higher forecast comes as Reckitt and other consumer goods companies struggle to raise prices in an ultra-competitive retail marketplace. However, the recent rise in commodities costs have forced some companies to pass these along to customers.

The company, once a pace-setter for the industry's sales growth, has been through hard times lately with Scholl dragging on sales for two years after the failure of electronic foot file that cost upwards of $40 to smooth dry heels.

However, the company said on Friday that it did not expect a material drag on its second-half results from Scholl.

The company posted total net revenue growth of 4 percent on a like-for-like basis, while pro-forma revenue rose 5 percent to 3.02 billion pounds for the three months ended June 30.

The maker of Mucinex cold medicine said the pro-forma growth was helped by 3 percent volume growth and a 1 percent boost from pricing mix in the second quarter.

"Still plenty to do to get back to the Reckitt Benckiser of old but after 8 disappointing quarters in a row, this is an important step in the right direction," Morgan Stanley analysts said in a note.

French food group Danone, which posted a 7.9 percent rise in first-half operating profit on Friday, also reported solid demand in China for baby food.

Nestle's improved performance in the second quarter was driven by a recovery in the sluggish U.S. market and in China as well as in infant nutrition.

Since January, Reckitt has been operating two units. Its health-related products, which make up most of the business, saw like-for-like sales up 3 percent, while its home and hygiene business that offers products like Harpic and Lysol rose 4 percent.

Shares of the company, which topped the UK bluechip index, were up 7.6 percent at 67.90 pounds at 0813 GMT.

(Reporting by Martinne Geller in London and Sangameswaran S in Bengaluru; editing by Jason Neely and Adrian Croft)

By Sangameswaran S

Stocks mentioned in the article
ChangeLast1st jan.
DANONE 0.90% 73.94 Real-time Quote.19.14%
NESTLÉ S.A. 0.41% 102.96 Delayed Quote.28.50%
RECKITT BENCKISER GROUP PLC 0.19% 5906 Delayed Quote.-1.91%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NESTLÉ S.A.
12/05Beyond Meat burgers to be sold at some Costco stores
12/05NESTLE S A : supports families with new parental leave policy
12/05NESTLE S A : DBRS Morningstar Confirms Nestle S.A. and Nestle Capital Canada Ltd..
12/04NESTLE S A : Barry Callebaut cites progress in helping cocoa farmers tackle chil..
12/04NESTLE S A : Nestlé supports families with new parental leave policy
12/02NESTLE S A : Purina announces the second BetterwithPets Prize
12/02Credit of Interim Cash Dividend of Nestle Pakistan Limited
11/28Nestle, Unilever, AB InBev Call For EU Laws on Zero-Emission Vehicles
11/27NESTLE S A : to use Nutri-Score nutrition-labelling in Europe
11/26Correction to article on consumer brands' plastic use
More news
Financials (CHF)
Sales 2019 93 216 M
EBIT 2019 16 458 M
Net income 2019 12 568 M
Debt 2019 27 624 M
Yield 2019 2,62%
P/E ratio 2019 24,2x
P/E ratio 2020 23,2x
EV / Sales2019 3,47x
EV / Sales2020 3,47x
Capitalization 296 B
Duration : Period :
Nestlé S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NESTLÉ S.A.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 111,57  CHF
Last Close Price 102,54  CHF
Spread / Highest target 19,0%
Spread / Average Target 8,81%
Spread / Lowest Target -14,2%
EPS Revisions
Ulf Mark Schneider Chief Executive Officer & Director
jeff hamilton President
Paul Bulcke Chairman
Magdi Batato Executive Vice President-Operations
François-Xavier Michel Marie Roger Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NESTLÉ S.A.28.50%299 897
DANONE19.14%52 584
GENERAL MILLS, INC.38.42%32 214